PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China. Electronic address: wunannan@shphc.org.cn.\', \'Shanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China; Department of Laboratory Medicine, Clinical Pathology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.\', \'Shanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China; Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Key Laboratory of Organ Transplantation, Zhongshan Hospital Fudan University, Shanghai, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1879-6257(21)00135-810.1016/j.coviro.2021.11.001
?:doi
?:hasPublicationType
?:journal
  • Current opinion in virology
is ?:pmid of
?:pmid
?:pmid
  • 34800893
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.69
?:rankingScore_hIndex
  • 50
is ?:relation_isRelatedTo_publication of
?:title
  • Phage therapy for secondary bacterial infections with COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all